David A. Ramsay, Director at LA JOLLA PHARMACEUTICAL CO (LJPC), bought 24,500 shares at $3.87 ($92K) on 2021-12-06, disclosed to the SEC on 2021-12-06.
Open-market purchase of $92k LJPC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.69 | 1,601 | $6K | 6.4% |
| 2 | $3.70 | 2,000 | $7K | 8.0% |
| 3 | $3.71 | 1,000 | $4K | 4.0% |
| 4 | $3.73 | 1,100 | $4K | 4.5% |
| 5 | $3.74 | 2,400 | $9K | 9.8% |
| 6 | $3.78 | 1,000 |
| $4K |
| 4.1% |
| 7 | $3.80 | 1,000 | $4K | 4.1% |
| 8 | $3.63 | 2,000 | $7K | 7.9% |
| 9 | $3.64 | 399 | $1K | 1.6% |
| 10 | $3.68 | 1,000 | $4K | 4.0% |
| 11 | $3.69 | 1,000 | $4K | 4.0% |
| 12 | $3.75 | 1,000 | $4K | 4.1% |
| 13 | $3.77 | 785 | $3K | 3.2% |
| 14 | $3.80 | 1,000 | $4K | 4.1% |
| 15 | $3.81 | 1,000 | $4K | 4.1% |
| 16 | $3.82 | 2,215 | $8K | 9.2% |
| 17 | $3.84 | 1,000 | $4K | 4.2% |
| 18 | $3.87 | 3,000 | $12K | 12.6% |
| Total | $3.75 avg | 24,500 | $92K | 100% |
| Filing → |
| SVRA | BUY | 2024-11-18 | $288K | — | Filing → |
| SVRA | BUY | 2023-05-26 | $356K | — | Filing → |
| SVRA | BUY | 2023-01-03 | $56K | — | Filing → |